A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China

NCT04830826 · clinicaltrials.gov ↗

COMPLETED

Status

1490

Enrollment

OTHER

Sponsor class

Conditions

NSCLC, Stage I
NSCLC, Stage II
NSCLC, Stage III

Interventions

PROCEDURE: Surgeries

Sponsor

The First Affiliated Hospital of Guangzhou Medical University